VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q64730220 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010848.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q64730220‏
024 ‎‡a 0000-0002-0191-4504‏ ‎‡2 orcid‏
024 ‎‡a 6602824949‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q64730220‏
100 0 ‎‡a Juan Francisco Merino-Torres‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Juan Francisco Merino-Torres‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Juan Francisco Merino-Torres‏ ‎‡c investigador‏ ‎‡9 es‏
670 ‎‡a Author's A case of lipoatrophy with insulin detemir‏
670 ‎‡a Author's A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.‏
670 ‎‡a Author's Adrenal insufficiency induced by megestrol acetate: Report of two cases‏
670 ‎‡a Author's Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant‏
670 ‎‡a Author's Autoimmune Diabetes Recurrence After Pancreas Transplantation: Diagnosis, Management, and Literature Review‏
670 ‎‡a Author's Brain abscess as the initial presentation of a macroprolactinoma: Case report‏
670 ‎‡a Author's Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study‏
670 ‎‡a Author's Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial‏
670 ‎‡a Author's [Chronic autoimmune urticaria as a possible non endocrine manifestation of autoimmune polyglandular syndrome type II]‏
670 ‎‡a Author's Clinical Practice Experiences Using a Professional Diabetes Management Ecosystem During COVID‏
670 ‎‡a Author's [Consensus on the diagnosis and management of changes in carbohydrate metabolism in cystic fibrosis]‏
670 ‎‡a Author's Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus‏
670 ‎‡a Author's Detection of glucose abnormalities in patients with acute coronary heart disease: study of reliable tools in clinical practice.‏
670 ‎‡a Author's Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid‏
670 ‎‡a Author's Diffuse alveolar hemorrhage as first manifestation of a pheochromocytoma‏
670 ‎‡a Author's Documento de posicionamiento: evaluación y manejo de la hipoglucemia en el paciente concon diabetes mellitus. Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición‏
670 ‎‡a Author's Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m2?: a Meta-analysis‏
670 ‎‡a Author's Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings‏
670 ‎‡a Author's Ectopic thyroid tissue and Graves' disease in an elderly patient.‏
670 ‎‡a Author's Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain‏
670 ‎‡a Author's Giardia intestinalis and Fructose Malabsorption: A Frequent Association‏
670 ‎‡a Author's GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes.‏
670 ‎‡a Author's GLP 1 receptor agonists, glycemic variability, oxidative stress and acute coronary syndrome‏
670 ‎‡a Author's Hashimoto's thyroiditis presenting as Graves-Basedow disease‏
670 ‎‡a Author's Hemoglobin Glycosylation Index is not related with blood glucose.‏
670 ‎‡a Author's Hepatic and pancreatic fat as imaging biomarkers of metabolic syndrome‏
670 ‎‡a Author's Hyperthyroidism induced by topical iodine‏
670 ‎‡a Author's Importance of technical aspects in the beginnings of a pancreas transplantation program.‏
670 ‎‡a Author's Insulin-Induced Normoglycemia Reduces Islet Number Needed to Achieve Normoglycemia after Allogeneic Islet Transplantation in Diabetic Mice.‏
670 ‎‡a Author's Integration of Distributed Services and Hybrid Models Based on Process Choreography to Predict and Detect Type 2 Diabetes.‏
670 ‎‡a Author's Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years.‏
670 ‎‡a Author's [Lung transplantation and the development of diabetes mellitus in adult patients with cystic fibrosis]‏
670 ‎‡a Author's Metabolic acidosis as a complication of intravenous dextrose administration in a patient with insulinoma.‏
670 ‎‡a Author's Obesity and type 2 diabetes: Also linked in therapuetic options‏
670 ‎‡a Author's Optimal timing of insulin detemir injection in patients with type 1 diabetes and poor metabolic control‏
670 ‎‡a Author's Outcomes in patients with diabetes 10 years after liver transplantation.‏
670 ‎‡a Author's [Pituitary apoplexy in a pregnant woman with cystic microprolactinoma]‏
670 ‎‡a Author's Plasma cell granuloma of the thyroid and Hashimoto thyroiditis.‏
670 ‎‡a Author's [Prevalence of malnutrition in a mid-long term stay unit]‏
670 ‎‡a Author's Prevalence of sarcopenia in a media and long stay Unit‏
670 ‎‡a Author's Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal‏
670 ‎‡a Author's Research in sarcopenia: Importance of methodology. Reply‏
670 ‎‡a Author's Severe hypoglycemia after gastric bypass surgery for morbid obesity‏
670 ‎‡a Author's Simultaneous Pancreas Kidney Transplantation Improves Cardiovascular Autonomic Neuropathy with Improved Valsalva Ratio as the Most Precocious Test‏
670 ‎‡a Author's [The limitations of catheterization of the inferior petrosal sinus in the differential diagnosis of Cushing's syndrome]‏
670 ‎‡a Author's [Thyroid lymphoma: a not so unusual disease]‏
670 ‎‡a Author's Unusual metastasis of differentiated thyroid carcinoma‏
670 ‎‡a Author's Valoración y control del riesgo metabólico y cardiovascular en los pacientes con esquizofrenia‏
670 ‎‡a Author's Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results‏
670 ‎‡a Author's What do healthcare professionals need to turn risk models for type 2 diabetes into usable computerized clinical decision support systems? Lessons learned from the MOSAIC project‏
909 ‎‡a (orcid) 0000000201914504‏ ‎‡9 1‏
909 ‎‡a (scopus) 6602824949‏ ‎‡9 1‏
919 ‎‡a intensifiedbloodglucosetreatmentindiabeticpatientsundergoingalivertransplantimpactongraftevolutionat3monthsandat5years‏ ‎‡A Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years.‏ ‎‡9 1‏
919 ‎‡a whatdohealthcareprofessionalsneedtoturnriskmodelsfortype2diabetesintousablecomputerizedclinicaldecisionsupportsystemslessonslearnedfromthemosaicproject‏ ‎‡A What do healthcare professionals need to turn risk models for type 2 diabetes into usable computerized clinical decision support systems? Lessons learned from the MOSAIC project‏ ‎‡9 1‏
919 ‎‡a websupportforweightlossinterventionspredircam2clinicaltrialbaselinecharacteristicsandpreliminaryresults‏ ‎‡A Web Support for Weight-Loss Interventions: PREDIRCAM2 Clinical Trial Baseline Characteristics and Preliminary Results‏ ‎‡9 1‏
919 ‎‡a valoracionycontroldelriesgometabolicoycardiovascularenlospacientesconesquizofrenia‏ ‎‡A Valoración y control del riesgo metabólico y cardiovascular en los pacientes con esquizofrenia‏ ‎‡9 1‏
919 ‎‡a unusualmetastasisofdifferentiatedthyroidcarcinoma‏ ‎‡A Unusual metastasis of differentiated thyroid carcinoma‏ ‎‡9 1‏
919 ‎‡a thyroidlymphomaanotsounusualdisease‏ ‎‡A [Thyroid lymphoma: a not so unusual disease]‏ ‎‡9 1‏
919 ‎‡a limitationsofcatheterizationoftheinferiorpetrosalsinusinthedifferentialdiagnosisofcushingssyndrome‏ ‎‡A [The limitations of catheterization of the inferior petrosal sinus in the differential diagnosis of Cushing's syndrome]‏ ‎‡9 1‏
919 ‎‡a simultaneouspancreaskidneytransplantationimprovescardiovascularautonomicneuropathywithimprovedvalsalvaratioasthemostprecocioustest‏ ‎‡A Simultaneous Pancreas Kidney Transplantation Improves Cardiovascular Autonomic Neuropathy with Improved Valsalva Ratio as the Most Precocious Test‏ ‎‡9 1‏
919 ‎‡a severehypoglycemiaaftergastricbypasssurgeryformorbidobesity‏ ‎‡A Severe hypoglycemia after gastric bypass surgery for morbid obesity‏ ‎‡9 1‏
919 ‎‡a researchinsarcopeniaimportanceofmethodologyreply‏ ‎‡A Research in sarcopenia: Importance of methodology. Reply‏ ‎‡9 1‏
919 ‎‡a preventionandmanagementofhormonalcrisisduringtheragnosiswithludotatateinneuroendocrinetumorsasystematicreviewandapproachproposal‏ ‎‡A Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal‏ ‎‡9 1‏
919 ‎‡a prevalenceofsarcopeniainamediaandlongstayunit‏ ‎‡A Prevalence of sarcopenia in a media and long stay Unit‏ ‎‡9 1‏
919 ‎‡a prevalenceofmalnutritioninamidlongtermstayunit‏ ‎‡A [Prevalence of malnutrition in a mid-long term stay unit]‏ ‎‡9 1‏
919 ‎‡a plasmacellgranulomaofthethyroidandhashimotothyroiditis‏ ‎‡A Plasma cell granuloma of the thyroid and Hashimoto thyroiditis.‏ ‎‡9 1‏
919 ‎‡a outcomesinpatientswithdiabetes10yearsafterlivertransplantation‏ ‎‡A Outcomes in patients with diabetes 10 years after liver transplantation.‏ ‎‡9 1‏
919 ‎‡a optimaltimingofinsulindetemirinjectioninpatientswithtype1diabetesandpoormetaboliccontrol‏ ‎‡A Optimal timing of insulin detemir injection in patients with type 1 diabetes and poor metabolic control‏ ‎‡9 1‏
919 ‎‡a obesityandtype2diabetesalsolinkedintherapueticoptions‏ ‎‡A Obesity and type 2 diabetes: Also linked in therapuetic options‏ ‎‡9 1‏
919 ‎‡a metabolicacidosisasacomplicationofintravenousdextroseadministrationinapatientwithinsulinoma‏ ‎‡A Metabolic acidosis as a complication of intravenous dextrose administration in a patient with insulinoma.‏ ‎‡9 1‏
919 ‎‡a lungtransplantationandthedevelopmentofdiabetesmellitusinadultpatientswithcysticfibrosis‏ ‎‡A [Lung transplantation and the development of diabetes mellitus in adult patients with cystic fibrosis]‏ ‎‡9 1‏
919 ‎‡a caseoflipoatrophywithinsulindetemir‏ ‎‡A A case of lipoatrophy with insulin detemir‏ ‎‡9 1‏
919 ‎‡a nationalsurveyontheefficacyandsafetyofcontinuoussubcutaneousinsulininfusioninpatientswithtype1diabetesinspain‏ ‎‡A A national survey on the efficacy and safety of continuous subcutaneous insulin infusion in patients with type 1 diabetes in Spain.‏ ‎‡9 1‏
919 ‎‡a adrenalinsufficiencyinducedbymegestrolacetatereportof2cases‏ ‎‡A Adrenal insufficiency induced by megestrol acetate: Report of two cases‏ ‎‡9 1‏
919 ‎‡a alterationsincarbohydratemetabolismincirrhoticpatientsbeforeandafterlivertransplant‏ ‎‡A Alterations in carbohydrate metabolism in cirrhotic patients before and after liver transplant‏ ‎‡9 1‏
919 ‎‡a autoimmunediabetesrecurrenceafterpancreastransplantationdiagnosismanagementandliteraturereview‏ ‎‡A Autoimmune Diabetes Recurrence After Pancreas Transplantation: Diagnosis, Management, and Literature Review‏ ‎‡9 1‏
919 ‎‡a brainabscessastheinitialpresentationofamacroprolactinomacasereport‏ ‎‡A Brain abscess as the initial presentation of a macroprolactinoma: Case report‏ ‎‡9 1‏
919 ‎‡a pituitaryapoplexyinapregnantwomanwithcysticmicroprolactinoma‏ ‎‡A [Pituitary apoplexy in a pregnant woman with cystic microprolactinoma]‏ ‎‡9 1‏
919 ‎‡a cardiovascularriskreductionovertimeinpatientswithdiabetesorprediabetesundergoingbariatricsurgerydatafromasinglecenterretrospectiveobservationalstudy‏ ‎‡A Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study‏ ‎‡9 1‏
919 ‎‡a cardiovascularsafetyoforalsemaglutideinpatientswithtype2diabetesrationaledesignandpatientbaselinecharacteristicsforthepioneer6trial‏ ‎‡A Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial‏ ‎‡9 1‏
919 ‎‡a chronicautoimmuneurticariaasapossiblenonendocrinemanifestationofautoimmunepolyglandularsyndrometype2‏ ‎‡A [Chronic autoimmune urticaria as a possible non endocrine manifestation of autoimmune polyglandular syndrome type II]‏ ‎‡9 1‏
919 ‎‡a clinicalpracticeexperiencesusingaprofessionaldiabetesmanagementecosystemduringcovid‏ ‎‡A Clinical Practice Experiences Using a Professional Diabetes Management Ecosystem During COVID‏ ‎‡9 1‏
919 ‎‡a consensusonthediagnosisandmanagementofchangesincarbohydratemetabolismincysticfibrosis‏ ‎‡A [Consensus on the diagnosis and management of changes in carbohydrate metabolism in cystic fibrosis]‏ ‎‡9 1‏
919 ‎‡a costanalysisoftheflashmonitoringsystemfreestylelibre2inadultswithtype1diabetesmellitus‏ ‎‡A Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus‏ ‎‡9 1‏
919 ‎‡a detectionofglucoseabnormalitiesinpatientswithacutecoronaryheartdiseasestudyofreliabletoolsinclinicalpractice‏ ‎‡A Detection of glucose abnormalities in patients with acute coronary heart disease: study of reliable tools in clinical practice.‏ ‎‡9 1‏
919 ‎‡a differentiatedthyroidcarcinomainagirlwithresistancetothyroidhormonemanagementwithtriiodothyroaceticacid‏ ‎‡A Differentiated thyroid carcinoma in a girl with resistance to thyroid hormone management with triiodothyroacetic acid‏ ‎‡9 1‏
919 ‎‡a diffusealveolarhemorrhageas1manifestationofapheochromocytoma‏ ‎‡A Diffuse alveolar hemorrhage as first manifestation of a pheochromocytoma‏ ‎‡9 1‏
919 ‎‡a documentodeposicionamientoevaluacionymanejodelahipoglucemiaenelpacienteconcondiabetesmellitusgrupodetrabajodediabetesmellitusdelasociedadespanoladeendocrinologiaynutricion‏ ‎‡A Documento de posicionamiento: evaluación y manejo de la hipoglucemia en el paciente concon diabetes mellitus. Grupo de Trabajo de Diabetes Mellitus de la Sociedad Española de Endocrinología y Nutrición‏ ‎‡9 1‏
919 ‎‡a doesmetabolicsurgeryleadtodiabetesremissioninpatientswithbmi30kgm2ametaanalysis‏ ‎‡A Does Metabolic Surgery Lead to Diabetes Remission in Patients with BMI < 30 kg/m2?: a Meta-analysis‏ ‎‡9 1‏
919 ‎‡a drivingtype2diabetesriskscoresintoclinicalpracticeperformanceanalysisinhospitalsettings‏ ‎‡A Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings‏ ‎‡9 1‏
919 ‎‡a ectopicthyroidtissueandgravesdiseaseinanelderlypatient‏ ‎‡A Ectopic thyroid tissue and Graves' disease in an elderly patient.‏ ‎‡9 1‏
919 ‎‡a flashglucosemonitoringreducesglycemicvariabilityandhypoglycemiarealworlddatafromspain‏ ‎‡A Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain‏ ‎‡9 1‏
919 ‎‡a giardiaintestinalisandfructosemalabsorptionafrequentassociation‏ ‎‡A Giardia intestinalis and Fructose Malabsorption: A Frequent Association‏ ‎‡9 1‏
919 ‎‡a glp1receptoragonistsandcardiovasculardiseaseinpatientswithtype2diabetes‏ ‎‡A GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes.‏ ‎‡9 1‏
919 ‎‡a glp1receptoragonistsglycemicvariabilityoxidativestressandacutecoronarysyndrome‏ ‎‡A GLP 1 receptor agonists, glycemic variability, oxidative stress and acute coronary syndrome‏ ‎‡9 1‏
919 ‎‡a hashimotosthyroiditispresentingasgravesbasedowdisease‏ ‎‡A Hashimoto's thyroiditis presenting as Graves-Basedow disease‏ ‎‡9 1‏
919 ‎‡a hemoglobinglycosylationindexisnotrelatedwithbloodglucose‏ ‎‡A Hemoglobin Glycosylation Index is not related with blood glucose.‏ ‎‡9 1‏
919 ‎‡a hepaticandpancreaticfatasimagingbiomarkersofmetabolicsyndrome‏ ‎‡A Hepatic and pancreatic fat as imaging biomarkers of metabolic syndrome‏ ‎‡9 1‏
919 ‎‡a hyperthyroidisminducedbytopicaliodine‏ ‎‡A Hyperthyroidism induced by topical iodine‏ ‎‡9 1‏
919 ‎‡a importanceoftechnicalaspectsinthebeginningsofapancreastransplantationprogram‏ ‎‡A Importance of technical aspects in the beginnings of a pancreas transplantation program.‏ ‎‡9 1‏
919 ‎‡a insulininducednormoglycemiareducesisletnumberneededtoachievenormoglycemiaafterallogeneicislettransplantationindiabeticmice‏ ‎‡A Insulin-Induced Normoglycemia Reduces Islet Number Needed to Achieve Normoglycemia after Allogeneic Islet Transplantation in Diabetic Mice.‏ ‎‡9 1‏
919 ‎‡a integrationofdistributedservicesandhybridmodelsbasedonprocesschoreographytopredictanddetecttype2diabetes‏ ‎‡A Integration of Distributed Services and Hybrid Models Based on Process Choreography to Predict and Detect Type 2 Diabetes.‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 LC|n 85806499‏
996 ‎‡2 SUDOC|035040688‏
996 ‎‡2 ISNI|000000005944845X‏
996 ‎‡2 LC|n 2002098544‏
996 ‎‡2 BNCHL|10000000000000000107077‏
996 ‎‡2 SUDOC|066991714‏
996 ‎‡2 BNF|16558811‏
996 ‎‡2 BNE|XX5465820‏
996 ‎‡2 BNC|981058516704506706‏
996 ‎‡2 NII|DA06427981‏
996 ‎‡2 BNE|XX5705759‏
996 ‎‡2 DNB|1057344982‏
996 ‎‡2 LC|ns2014001748‏
996 ‎‡2 DNB|1053072554‏
996 ‎‡2 PLWABN|9814024545705606‏
996 ‎‡2 ISNI|0000000401713600‏
996 ‎‡2 DNB|136147844‏
996 ‎‡2 ISNI|0000000059294868‏
996 ‎‡2 ISNI|0000000073418484‏
996 ‎‡2 ISNI|0000000051551874‏
996 ‎‡2 BNE|XX897618‏
996 ‎‡2 LC|no2018068657‏
996 ‎‡2 ISNI|0000000121432986‏
996 ‎‡2 BNE|XX1040723‏
996 ‎‡2 ISNI|0000000117810729‏
996 ‎‡2 ISNI|0000000084164010‏
996 ‎‡2 BNE|XX1030768‏
996 ‎‡2 ISNI|0000000060915828‏
996 ‎‡2 LC|n 2009042012‏
996 ‎‡2 ISNI|0000000060319110‏
996 ‎‡2 ISNI|0000000408271753‏
996 ‎‡2 ISNI|0000000080053591‏
996 ‎‡2 LC|ns2013003002‏
996 ‎‡2 ISNI|0000000078257894‏
996 ‎‡2 SUDOC|066013720‏
996 ‎‡2 NTA|375039295‏
996 ‎‡2 BNE|XX5397033‏
996 ‎‡2 DNB|1064588662‏
996 ‎‡2 PTBNP|217247‏
996 ‎‡2 PLWABN|9810650798105606‏
996 ‎‡2 DNB|1057341819‏
996 ‎‡2 CAOONL|ncf11573586‏
996 ‎‡2 LC|no2024000176‏
996 ‎‡2 BNC|981058612228306706‏
996 ‎‡2 RERO|A018540243‏
996 ‎‡2 BNE|XX1781451‏
996 ‎‡2 BNCHL|10000000000000000069143‏
996 ‎‡2 BNC|981058528668506706‏
996 ‎‡2 ISNI|000000010043013X‏
996 ‎‡2 LC|n 92101874‏
996 ‎‡2 LC|nb2005011542‏
996 ‎‡2 ISNI|0000000044938894‏
996 ‎‡2 LC|n 2003048397‏
996 ‎‡2 BNE|XX1658850‏
996 ‎‡2 BNCHL|10000000000000000212961‏
996 ‎‡2 LC|n 2007069566‏
996 ‎‡2 J9U|987007345263905171‏
996 ‎‡2 LC|ns2012005335‏
996 ‎‡2 LC|no 94021363‏
996 ‎‡2 LC|no 98078975‏
996 ‎‡2 BNF|13744562‏
996 ‎‡2 NLA|000061541731‏
996 ‎‡2 LC|ns2013000873‏
996 ‎‡2 SUDOC|152862412‏
996 ‎‡2 ISNI|0000000117742009‏
996 ‎‡2 LC|n 2022048039‏
996 ‎‡2 ISNI|0000000061090717‏
996 ‎‡2 PLWABN|9811724166705606‏
996 ‎‡2 LC|n 93107905‏
996 ‎‡2 ISNI|0000000087051070‏
996 ‎‡2 LC|nb2009027776‏
996 ‎‡2 ISNI|0000000001274071‏
996 ‎‡2 DNB|133006328‏
996 ‎‡2 LC|ns2011001949‏
996 ‎‡2 LC|no 98026822‏
996 ‎‡2 LC|ns2020000921‏
996 ‎‡2 BAV|495_181817‏
996 ‎‡2 LC|no2014125371‏
996 ‎‡2 ISNI|0000000053912792‏
996 ‎‡2 BNE|XX1791739‏
996 ‎‡2 ISNI|0000000068100834‏
996 ‎‡2 ISNI|000000005924836X‏
996 ‎‡2 BNCHL|10000000000000000866413‏
996 ‎‡2 RERO|A012071925‏
996 ‎‡2 LC|n 94015880‏
996 ‎‡2 LC|no2018091119‏
996 ‎‡2 SUDOC|120162199‏
996 ‎‡2 BNF|16973307‏
996 ‎‡2 BNE|XX1577604‏
996 ‎‡2 SUDOC|033315345‏
996 ‎‡2 DNB|1112337601‏
996 ‎‡2 ISNI|0000000428291110‏
996 ‎‡2 BNE|XX1721051‏
996 ‎‡2 NTA|307981363‏
996 ‎‡2 DNB|112555276X‏
996 ‎‡2 DNB|1089781296‏
996 ‎‡2 LC|n 2010027205‏
996 ‎‡2 ISNI|0000000118442956‏
996 ‎‡2 LC|n 86869124‏
996 ‎‡2 BNE|XX6517693‏
996 ‎‡2 ISNI|0000000066337520‏
996 ‎‡2 LC|n 99022813‏
996 ‎‡2 SUDOC|130897019‏
996 ‎‡2 SUDOC|115260625‏
996 ‎‡2 LC|no2015134221‏
996 ‎‡2 SUDOC|134236793‏
996 ‎‡2 BNE|XX1240974‏
996 ‎‡2 NTA|168669897‏
996 ‎‡2 LC|n 2016068176‏
996 ‎‡2 PTBNP|1496782‏
996 ‎‡2 SUDOC|170409872‏
996 ‎‡2 LC|n 93023682‏
996 ‎‡2 LC|ns2011001235‏
996 ‎‡2 J9U|987007330159505171‏
996 ‎‡2 BNC|981058514327206706‏
996 ‎‡2 BNE|XX825767‏
996 ‎‡2 BNE|XX5433310‏
996 ‎‡2 ISNI|0000000072454029‏
996 ‎‡2 BNC|981061093964406706‏
996 ‎‡2 SUDOC|236638343‏
996 ‎‡2 BNE|XX1455376‏
996 ‎‡2 ISNI|000000002846561X‏
996 ‎‡2 LC|ns2021002706‏
996 ‎‡2 SUDOC|177389710‏
996 ‎‡2 BNC|981058530827106706‏
996 ‎‡2 DNB|1202732615‏
996 ‎‡2 DNB|143298712‏
996 ‎‡2 BNCHL|10000000000000000820967‏
996 ‎‡2 LC|no 00022631‏
996 ‎‡2 LC|n 2014034285‏
996 ‎‡2 LC|ns2021003235‏
996 ‎‡2 BNE|XX5437745‏
996 ‎‡2 BNE|XX5223054‏
996 ‎‡2 LC|n 85087728‏
996 ‎‡2 ISNI|0000000059317185‏
996 ‎‡2 ISNI|0000000076716794‏
996 ‎‡2 DNB|138388830‏
996 ‎‡2 BNE|XX835070‏
996 ‎‡2 BNE|XX1791011‏
996 ‎‡2 LC|no2004000519‏
996 ‎‡2 PLWABN|9810542392505606‏
996 ‎‡2 NSK|000611132‏
996 ‎‡2 RERO|A005714359‏
996 ‎‡2 NUKAT|n 2017075671‏
996 ‎‡2 DNB|1157280412‏
996 ‎‡2 PLWABN|9810699837705606‏
996 ‎‡2 ISNI|000000005032424X‏
996 ‎‡2 LC|no2006069951‏
996 ‎‡2 BNE|XX1106461‏
996 ‎‡2 LC|n 85092380‏
996 ‎‡2 BNE|XX1166393‏
996 ‎‡2 LC|no2024138177‏
996 ‎‡2 LC|no2010169902‏
996 ‎‡2 NII|DA17664118‏
996 ‎‡2 BNE|XX5153416‏
996 ‎‡2 DNB|1208850466‏
996 ‎‡2 SUDOC|271067705‏
996 ‎‡2 LC|nb2013024050‏
996 ‎‡2 DNB|1056788798‏
996 ‎‡2 LC|n 98084031‏
996 ‎‡2 ISNI|0000000383413718‏
996 ‎‡2 ISNI|000000007063865X‏
996 ‎‡2 ISNI|0000000079735341‏
996 ‎‡2 LC|n 93077588‏
996 ‎‡2 ISNI|000000007498594X‏
996 ‎‡2 ISNI|0000000395089361‏
996 ‎‡2 BNE|XX1720664‏
996 ‎‡2 LC|n 50036793‏
996 ‎‡2 DNB|1056246111‏
996 ‎‡2 BNF|12572553‏
996 ‎‡2 ISNI|0000000118735951‏
996 ‎‡2 ISNI|0000000072287099‏
996 ‎‡2 ISNI|0000000078075783‏
996 ‎‡2 ISNI|0000000370832761‏
996 ‎‡2 SUDOC|258257202‏
996 ‎‡2 BNC|981060929701606706‏
996 ‎‡2 ISNI|0000000068294288‏
996 ‎‡2 DNB|143579258‏
996 ‎‡2 LC|n 2024061511‏
996 ‎‡2 LC|no2010181573‏
996 ‎‡2 PTBNP|249502‏
996 ‎‡2 BNE|XX1030075‏
996 ‎‡2 BNF|15584396‏
996 ‎‡2 LC|no2022093042‏
996 ‎‡2 LC|no2023000738‏
996 ‎‡2 BNCHL|10000000000000000249936‏
996 ‎‡2 SUDOC|228918456‏
996 ‎‡2 PLWABN|9810703186105606‏
996 ‎‡2 ISNI|0000000395103784‏
996 ‎‡2 BNC|981058611593206706‏
996 ‎‡2 LC|ns2023001660‏
996 ‎‡2 LC|nb2014026577‏
996 ‎‡2 LC|no2020124043‏
996 ‎‡2 BNF|16614034‏
996 ‎‡2 SUDOC|139255699‏
996 ‎‡2 ISNI|0000000118299643‏
996 ‎‡2 DNB|1274485371‏
996 ‎‡2 LC|n 92087220‏
996 ‎‡2 LC|no2013044469‏
996 ‎‡2 BNCHL|10000000000000000084864‏
996 ‎‡2 BNE|XX5664718‏
996 ‎‡2 CAOONL|ncf10529105‏
996 ‎‡2 BNE|XX4685865‏
996 ‎‡2 CAOONL|ncf11853547‏
996 ‎‡2 ISNI|0000000420369809‏
996 ‎‡2 BNE|XX6232150‏
996 ‎‡2 BNE|XX1455334‏
996 ‎‡2 ISNI|0000000459660441‏
996 ‎‡2 BNF|16242355‏
996 ‎‡2 LC|ns2019000044‏
996 ‎‡2 NTA|132136198‏
996 ‎‡2 LC|no2003049915‏
996 ‎‡2 DNB|1056419466‏
996 ‎‡2 SUDOC|200713736‏
996 ‎‡2 DNB|105775952X‏
996 ‎‡2 J9U|987007448037005171‏
996 ‎‡2 BNE|XX1143815‏
996 ‎‡2 DNB|1026519926‏
996 ‎‡2 NLR|RU NLR AUTH 770250078‏
996 ‎‡2 ISNI|0000000045696567‏
996 ‎‡2 ISNI|0000000514185349‏
996 ‎‡2 BNF|14550616‏
996 ‎‡2 LC|no2010008173‏
996 ‎‡2 BNE|XX4690788‏
996 ‎‡2 DNB|1055587543‏
996 ‎‡2 BNE|XX1080481‏
996 ‎‡2 BNC|981058514443506706‏
996 ‎‡2 ISNI|0000000060157764‏
996 ‎‡2 DE633|pe30108441‏
996 ‎‡2 ISNI|0000000072969428‏
996 ‎‡2 BIBSYS|8041876‏
996 ‎‡2 ISNI|0000000383767751‏
996 ‎‡2 ISNI|0000000061588507‏
996 ‎‡2 LC|nr 95033529‏
996 ‎‡2 LC|nb2011005508‏
996 ‎‡2 PTBNP|1531928‏
996 ‎‡2 ISNI|0000000359724719‏
996 ‎‡2 RERO|A021694085‏
996 ‎‡2 BNCHL|10000000000000000072941‏
996 ‎‡2 PTBNP|1017366‏
996 ‎‡2 DNB|135613523‏
996 ‎‡2 LC|no2008089571‏
996 ‎‡2 BNE|XX1006624‏
996 ‎‡2 LC|no2010061177‏
996 ‎‡2 BNC|981058511634806706‏
996 ‎‡2 BNC|981058518367106706‏
996 ‎‡2 SUDOC|256686009‏
996 ‎‡2 DNB|1212531035‏
996 ‎‡2 SUDOC|085981508‏
996 ‎‡2 BAV|495_269471‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏